Stem Cells Translational Medicine

Papers
(The H4-Index of Stem Cells Translational Medicine is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Identification and Successful Re-Consent of Existing Cord Blood Donors for the Creation of Induced Pluripotent Stem Cell Lines165
Abstract 17: IL10R Deficiency and Hemopoietic Cell Transplantation (HCT): Outcome of 2 Patients Treated in a Single Center with CBU HCT113
Abstract 28 Comparative Analysis of the Cord Blood Bank in Quebec66
Abstract 20 A Rapid and Sensitive IL-3-Based Assay Reveals How Various Pre-Processing Conditions Affect the Potency of Hematopoietic Stem Cells in Fresh Cord Blood Units61
Cancer Stem Cells and Cell Cycle Genes as Independent Predictors of Relapse in Non-small Cell Lung Cancer: Secondary Analysis of a Prospective Study52
NLRP3 and AIM2 inflammasomes expression is modified by LPS and titanium ions increasing the release of active IL-1β in alveolar bone-derived MSCs50
Abstract 2 Development of CAR-NK Cell Therapy for Hematologic Malignancies42
Pretreatment with Perlecan-Conjugated Laminin-E8 Fragment Enhances Maturation of Grafted Dopaminergic Progenitors in Parkinson’s Disease Model39
Cellular and Molecular Targets of Extracellular Vesicles from Mesenchymal Stem/Stromal Cells in Rheumatoid Arthritis38
Nose-to-brain delivery of stem cells in stroke: the role of extracellular vesicles37
CRISPRthripsis: The Risk of CRISPR/Cas9-induced Chromothripsis in Gene Therapy35
Single-Cell RNA-Seq Reveals LRRC75A-Expressing Cell Population Involved in VEGF Secretion of Multipotent Mesenchymal Stromal/Stem Cells Under Ischemia34
Improved MSC Minimal Criteria to Maximize Patient Safety: A Call to Embrace Tissue Factor and Hemocompatibility Assessment of MSC Products33
An Urgent Need for Standardization of Stem Cells and Stem Cell-derived Products Toward Clinical Applications33
Mesenchymal Stromal Cell Mitochondrial Transfer as a Cell Rescue Strategy in Regenerative Medicine: A Review of Evidence in Preclinical Models31
Volume 11 Acknowledgments30
Initial or continuous coculture with umbilical cord-derived mesenchymal stromal cells facilitates in vitro expansion of human regulatory T-cell subpopulations30
Safety and Efficacy of the Intra-articular Injection of Mesenchymal Stem Cells for the Treatment of Osteoarthritic Knee: A 5-Year Follow-up Study30
IFSC 2020 Meeting Report29
29
Abstract 1 Clinical and Imaging Outcomes After Allogenic Umbilical Cord Blood Transfusions in a Young Adult with Cerebral Palsy28
Abstract 28 A Novel Chemically Defined Culturing System to Support Hematopoietic Stem Cell Expansion28
A Randomized, Placebo-Controlled, Phase II Trial of Intravenous Allogeneic Non-HLA Matched, Unrelated Donor, Cord Blood Infusion for Ischemic Stroke27
Rejuvenation of Tissue Stem Cells by Intrinsic and Extrinsic Factors27
Comparing the Therapeutic Mechanism and Immune Response of Human and Mouse Mesenchymal Stem Cells in Immunocompetent Mice With Acute Liver Failure27
Mitigation of supply chain challenges in cell therapy manufacturing: perspectives from the cord blood alliance27
Mechanical force-activated CD109 on periodontal ligament stem cells governs osteogenesis and osteoclast to promote alveolar bone remodeling27
0.068381071090698